drugset / Trial / NCT00039572

Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain

NCT00039572 ↗

Treatment

Summary

RATIONALE: Radiation therapy such as boron neutron capture therapy may kill tumor cells without harming normal tissue. PURPOSE: Phase I/II trial to study the effectiveness of boron neutron capture therapy in treating patients who have glioblastoma multiforme or melanoma metastatic to the brain.

Timeline

Start
2002-05
Primary completion
—
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject boronophenylalanine-fructose complex Unknown — Intravenous